JP2022517865A5 - - Google Patents
Info
- Publication number
- JP2022517865A5 JP2022517865A5 JP2021543528A JP2021543528A JP2022517865A5 JP 2022517865 A5 JP2022517865 A5 JP 2022517865A5 JP 2021543528 A JP2021543528 A JP 2021543528A JP 2021543528 A JP2021543528 A JP 2021543528A JP 2022517865 A5 JP2022517865 A5 JP 2022517865A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962797573P | 2019-01-28 | 2019-01-28 | |
| US62/797,573 | 2019-01-28 | ||
| PCT/US2020/015457 WO2020160022A1 (en) | 2019-01-28 | 2020-01-28 | Compositions and methods for treatment of diseases involving cxcl1 function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022517865A JP2022517865A (ja) | 2022-03-10 |
| JPWO2020160022A5 JPWO2020160022A5 (https=) | 2023-02-03 |
| JP2022517865A5 true JP2022517865A5 (https=) | 2023-02-03 |
Family
ID=71841416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543528A Pending JP2022517865A (ja) | 2019-01-28 | 2020-01-28 | Ｃｘｃｌ１機能に関与する疾患の治療のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11292832B2 (https=) |
| EP (1) | EP3917949A4 (https=) |
| JP (1) | JP2022517865A (https=) |
| CN (1) | CN113544143A (https=) |
| CA (1) | CA3127943A1 (https=) |
| WO (1) | WO2020160022A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3249959A1 (en) * | 2022-01-27 | 2025-06-17 | Chiome Bioscience Inc. | ANTI-CXCL1 HUMAN ANTIBODY |
| WO2026060413A1 (en) * | 2024-09-16 | 2026-03-19 | Calgent Biotechnology Co., Ltd. | Single chain antibodies and use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910316B2 (en) * | 2005-09-02 | 2011-03-22 | Toray Industries, Inc. | Kit and method for detecting urothelial cancer |
| US7858752B2 (en) | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
| CN101261275A (zh) * | 2008-01-23 | 2008-09-10 | 李力 | 一种用于早期卵巢癌诊断的检测试剂盒 |
| WO2010050552A1 (ja) | 2008-10-29 | 2010-05-06 | 日本ゼオン株式会社 | ニトリル共重合体ラテックス組成物およびニトリル共重合体ゴム組成物 |
| KR101682257B1 (ko) | 2008-10-31 | 2016-12-05 | 도레이 카부시키가이샤 | 인간 ｃｘｃｌ１ 단백질의 면역학적 측정 방법 |
| US8900588B2 (en) | 2010-01-08 | 2014-12-02 | Les Laboratories Servier | Methods for treating breast cancer |
| WO2014113804A1 (en) * | 2013-01-21 | 2014-07-24 | Abbvie Inc. | Anti-tnf and anti-il17 combination therapy biomarkers for inflammatory disease |
| US9290570B2 (en) | 2013-03-15 | 2016-03-22 | Eli Lilly And Company | Pan-ELR+ CXC Chemokine Antibodies |
| EP2997042B1 (en) | 2013-05-17 | 2019-08-07 | Centre National de la Recherche Scientifique (CNRS) | Anti-cxcl1, cxcl7 and cxcl8 antibodies and their applications |
| WO2019055776A2 (en) * | 2017-09-14 | 2019-03-21 | Rosser Charles | COMPOSITIONS AND METHODS FOR TREATING DISEASES INVOLVING CXCL1 FUNCTION |
| US11603569B2 (en) * | 2018-03-20 | 2023-03-14 | Cedars-Sinai Medical Center | Immune modulating genes for prognosis, diagnosis and treatment of metastatic disease, and drug identification methods thereof |
-
2020
- 2020-01-28 US US16/982,456 patent/US11292832B2/en active Active
- 2020-01-28 EP EP20747679.7A patent/EP3917949A4/en active Pending
- 2020-01-28 WO PCT/US2020/015457 patent/WO2020160022A1/en not_active Ceased
- 2020-01-28 CA CA3127943A patent/CA3127943A1/en active Pending
- 2020-01-28 CN CN202080017507.1A patent/CN113544143A/zh active Pending
- 2020-01-28 JP JP2021543528A patent/JP2022517865A/ja active Pending
-
2022
- 2022-03-07 US US17/688,740 patent/US11760796B2/en active Active
-
2023
- 2023-08-18 US US18/451,872 patent/US20240018229A1/en active Pending